Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein M.

Guanghua Luo1, Xiaoying Zhang, Peter Nilsson-Ehle

  • 1Department of Clinical Chemistry, Institute of Laboratory Medicine, University Hospital of Lund, S-221 85 Lund, Sweden. shineroar@163.com

Lipids in Health and Disease
|October 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactive oxygen species (ROS)-responsive delivery of chlorantraniliprole by a nanoscale metal-phenolic network for systemic control of rice striped stem borer.

Journal of nanobiotechnology·2026
Same author

α-Helical peptides: design strategies and recent advances in biomedical applications.

Journal of translational medicine·2026
Same author

Extracellular vesicles from skin-derived precursor Schwann cells improve the microenvironment for peripheral nerve regeneration.

Neural regeneration research·2026
Same author

TTPAL inhibits the progression of breast cancer and reprograms tumor-associated macrophages by inhibiting JAK2/STAT3 signaling pathway.

Breast cancer research : BCR·2026
Same author

Sarcopenia in type 2 diabetes mellitus: an imaging review.

Frontiers in medicine·2026
Same author

Global profiling of lysine-malonylated proteins in rice elucidates the immune-regulatory mechanisms of malonylation under herbivore or viral stresses.

Journal of integrative plant biology·2025
Same journal

Association between glycolipid metabolism 7 factors (GLM7) and pregnancy loss in women aged 18-35 years: evidence from NHANES 2009-2018.

Lipids in health and disease·2026
Same journal

Gestational lipid profile partially mediates adverse obstetric outcomes associated with polycystic ovary syndrome: a multicentre cohort study in China.

Lipids in health and disease·2026
Same journal

Spatial anchoring of lipid metabolism shapes immune fate in the tumor microenvironment.

Lipids in health and disease·2026
Same journal

Baseline self-reported supplement category use and two-visit difference in lipoprotein(a): an observational analysis in UK Biobank.

Lipids in health and disease·2026
Same journal

Impact of altered HDL2b/HDL3 ratio on the function of innate immune cells in sepsis.

Lipids in health and disease·2026
Same journal

Interaction of hypertension and remnant cholesterol on arterial stiffness in Chinese middle-aged and elderly populations.

Lipids in health and disease·2026
See all related articles

Apolipoprotein M (apoM) is a protein found in human plasma, primarily linked to HDL. Its expression is regulated by factors like HNF-1alpha and leptin, impacting conditions such as MODY3 and obesity.

Area of Science:

  • Lipid metabolism and lipoprotein research
  • Gene expression and regulation
  • Human genetics and disease

Background:

  • Apolipoprotein M (apoM) is a 26-kDa protein primarily associated with high-density lipoprotein (HDL) in human plasma.
  • A small fraction of apoM is also found in triglyceride-rich lipoproteins (TGRLP) and low-density lipoproteins (LDL).
  • The human apoM gene is located on chromosome 6, and the protein belongs to the lipocalin superfamily.

Purpose of the Study:

  • To investigate the tissue-specific expression of apolipoprotein M.
  • To identify regulatory factors influencing apoM gene expression.
  • To explore the potential role of apoM in metabolic diseases like MODY3 and obesity.

Main Methods:

  • Human tissue expression array analysis to determine apoM expression sites.

Related Experiment Videos

  • In situ hybridization to localize apoM mRNA in hepatocytes and kidney tubule cells.
  • Analysis of apoM expression in genetically modified mouse models (apoA-I deficient, HNF-1alpha deficient, leptin deficient, leptin receptor deficient).

    • Main Results:

    • ApoM is predominantly expressed in the liver and kidney, specifically in hepatocytes and kidney tubule epithelial cells.
    • Platelet activating factor (PAF), transforming growth factors (TGF), insulin-like growth factor (IGF), and leptin can regulate apoM expression.
    • ApoM expression is significantly reduced in apoA-I deficient, HNF-1alpha deficient, leptin deficient (ob/ob), and leptin receptor deficient (db/db) mice.
    • Mutations in Hepatocyte nuclear factor-1alpha (HNF-1alpha), associated with MODY3, lead to reduced serum apoM levels.
    • Plasma apoM concentration correlates positively with leptin levels in obese individuals.

    Conclusions:

    • Apolipoprotein M expression is tightly regulated by specific transcription factors and hormones.
    • ApoM plays a role in lipid metabolism and may be implicated in the pathogenesis of MODY3 and obesity.
    • Further research into apoM's function could offer insights into metabolic disease treatment.